Peer-influenced content. Sources you trust. No registration required. This is HCN.
ACP Internist
Discover the optimal treatment strategy for a 38-year-old woman with an 11-mm kidney stone and renal calyceal dilation. What’s your next move?
Internal Medicine October 4th 2023
Renal & Urology News
Discover the key predictors of PSA persistence post-prostate cancer surgery and how they can inform your treatment plans and patient discussions.
Oncology, Medical October 2nd 2023
The New England Journal of Medicine
The recent phase 3 trial on 177Lu-PSMA-617 offers compelling evidence for its efficacy in extending survival rates for advanced prostate cancer patients. Could this therapy eventually become an addition to your treatment arsenal?
Discover how elevated periprostatic testosterone levels could influence treatment decisions and outcomes in prostate cancer. New insights call for revised preoperative evaluations.
Oncology, Medical September 25th 2023
New data suggests that intensifying neoadjuvant therapy with abiraterone or docetaxel could significantly improve outcomes in very high-risk prostate cancer patients. Explore the full findings to consider how this could impact your treatment approach.
Oncology, Medical September 19th 2023
Conexiant
This groundbreaking study provides new insights into the risk of prostate cancer in transgender women, emphasizing the need for tailored screening and awareness among healthcare providers.
Oncology, Medical September 11th 2023